MarketsStocksSAMRATPH
SA

Samrat Pharmachem Ltd-$

NSE: SAMRATPHBSE: 530125Healthcare
Download Research Report7-page PDF
206.00
-0.56%
NSE · auto-updates while market open
Mkt Cap
₹63 Cr
P / E
10.6
P / B
0.9
ROE
-4.7%
52W High
₹389.00
52W Low
₹190.00
Key Metrics
Market Cap
₹63 Cr
P / E
10.61
P / B
0.92
EV / EBITDA
7.44
ROCE
-2.5%
ROE
-4.7%
Debt / Equity
0.16
Book Value
₹220.67
EPS
-
Div Yield
0.0%
Face Value
-
Promoter Holding
49.1%
Revenue · ₹ Cr
137
FY20
179
FY21
222
FY22
311
FY23
282
FY24
286
FY25
290
FY26
Net Profit · ₹ Cr
4
5
17
17
2
7
-3
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹5.0
FY19
₹13.7
FY20
₹17.3
FY21
₹55.6
FY22
₹53.8
FY23
₹7.0
FY24
₹23.0
FY25
Q1 2026 snapshot
Sales
₹71 Cr
Operating profit
-
OPM
-
Net profit
₹-2 Cr
EPS
-
Scorecard · 7 axes
Quality
Weak
42/100
Valuation
Strong
10.6×
Growth
Avg
+7.2%
Profitability
Bad
-3.6%
Performance
Bad
-41.2%
Entry Point
Strong
53%
Red Flags
Strong
0 flags
Shareholding Pattern
49.1%Promoter
Promoter49.1%
FII3.2%
Public47.7%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue63.6771.176.3478.9263.8371.47
Net Profit2.785-0.399-0.229-0.587-0.46-2.036
NPM %4.4%-0.6%-0.3%-0.7%-0.7%-2.8%
AlertPre-trade